Chad J. Swanson - 27 Sep 2024 Form 3 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Chief Development Officer
Signature
/s/ Michael J. Malecek, as Attorney-in-Fact for Chad J. Swanson
Issuer symbol
PRTA
Transactions as of
27 Sep 2024
Transactions value $
$0
Form type
3
Filing time
03 Oct 2024, 18:57:44 UTC
Next filing
03 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PRTA Stock Option (Right to Buy) 27 Sep 2024 Ordinary Shares 85K $53.67 Direct F1
holding PRTA Stock Option (Right to Buy) 27 Sep 2024 Ordinary Shares 27K $30.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 1, 2024, and will vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
F2 The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2025, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney